Immune cell responses in COVID-19 patients far from optimal
Melbourne researchers have discovered that killer T cells, key immune cells in fighting viral infections, are present at much lower
Read more
Immune responses to tuberculosis mapped across three species
Tuberculosis (TB) is one of the world’s most vexing public health problems. About 1.5 million people died from this bacterial
Read more
BCMA-targeted immunotherapy can lead to durable responses in multiple myeloma
An experimental, off-the-shelf immunotherapy that combines a targeted antibody and chemotherapy can lead to potentially durable responses in multiple myeloma
Read more